|
Multi-site
research studies often include one or more "coordinating
centers" or "central laboratories" or "reading
centers." As pointed out in Appendix
P, these coordinating centers may vary widely in degree of
oversight, and the vast majority of these will require either
an expedited or full board review. The following application is
limited to coordinating or reading centers, or central laboratories,
in which staff receive no identifiable information from the individuals
whose data or specimens are being studied. For example, certain
data centers may receive either de-identified data or specimens,
or (more likely) data which has linkage codes the data center
does not have access to the linkage codes (the codes are maintained
at the clinical site where the data were originally collected).
Because staff at the data center have neither interacted nor intervened
with the individuals providing the data or specimens, and because
they will not be obtaining private, identifiable information,
this data center protocol would qualify for "no human subjects"
involvement, according to 45 CFR 46.102.f. This class of data
center necessarily has no oversight over the conduct of the study
at the local clinical sites; it is not involved in auditing activities
at the local sites (including auditing of source documents), it
is not involved in the development of consent forms at the local
sites, it does not keep a listing of subject names linked to ID
numbers, nor does it ever contact subjects (e.g., to schedule
appointments, obtain additional follow-up information, etc.).
If the data
center (or similar ancillary center) meets those criteria, the
following application can be completed and forwarded to the Exempt/Expedited
Review Team for a determination.
|